Contingency Management for Smoking Cessation Among Veterans With Psychotic Disorders
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study examines the use of contingent incentives to increase attendance at smoking cessation treatment sessions by smokers with schizophrenia and other psychoses who want to quit smoking. We hypothesize that participants randomized to receive contingent rewards for group attendance will attend more treatment sessions than those in the control group.
| Condition | Intervention |
|---|---|
|
Nicotine Dependence Psychotic Disorders |
Behavioral: Contingency Management Behavioral: Reward |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Contingency Management for Smoking Cessation Among Veterans With Schizophrenia or Other Psychoses |
- Number of treatment sessions attended [ Time Frame: 11 weeks ] [ Designated as safety issue: No ]
- Reduction in cigarettes per day [ Time Frame: 3 and 6 months ] [ Designated as safety issue: No ]
- 7- and 30-day point prevalence abstinence [ Time Frame: 3 and 6 months ] [ Designated as safety issue: No ]
- Continuous abstinence from quit date [ Time Frame: 3 and 6 months ] [ Designated as safety issue: No ]
- Days to relapse from quit date [ Time Frame: Up to 6 months ] [ Designated as safety issue: No ]
- Change in BPRS scores [ Time Frame: 3 and 6 months ] [ Designated as safety issue: No ]
- Change in PHQ-9 scores [ Time Frame: 3 and 6 months ] [ Designated as safety issue: No ]
| Enrollment: | 23 |
| Study Start Date: | July 2007 |
| Estimated Study Completion Date: | September 2013 |
| Estimated Primary Completion Date: | June 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Arm 1
Experimental
|
Behavioral: Contingency Management
Participants draw from a fishbowl to obtain tokens when they attend a smoking cessation treatment session. The number of draws will be based upon attendance at consecutive sessions. Tokens include messages of encouragement ("Good job!") or VA canteen vouchers of varying monetary value.
|
|
Active Comparator: Arm 2
Active Comparator
|
Behavioral: Reward
Participants receive set reward (VA canteen voucher) for each week of smoking cessation treatment they attend. The value of the reward will not change regardless of attendance at consecutive sessions.
|
Detailed Description:
Schizophrenia and other psychotic disorders are highly prevalent in the VA population and are associated with high rates of smoking. Although smoking cessations approaches that work for non-schizophrenic patients such as behavioral counseling and medications appear to be efficacious for schizophrenic smokers, a major obstacle in providing adequate treatment is poor attendance at treatment sessions. Contingency management has been shown to shape treatment behavior in non-schizophrenic smokers and to shape other behaviors such as cocaine use and exercise in schizophrenics.
The intention of this project is to examine the use of contingent incentives to increase attendance at smoking cessation treatment sessions by smokers with schizophrenia and other psychoses and to compare two different approaches to providing contingent incentives in this context. Subjects in the experimental condition draw from a fishbowl to obtain tokens when they attend a smoking cessation treatment session. The number of draws will be based upon attendance at consecutive sessions. Subjects in the experimental condition receive a set reward that will not change regardless of attendance at consecutive sessions. We hypothesize that the participants in the experimental condition will attend more smoking cessation group therapy sessions than those in the control condition because they will have the possibility, although not the likelihood, to obtain contingent reinforcement of greater value.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- All subjects must be diagnosed with schizophrenia or any other psychotic disorder, bipolar disorder with psychotic features, or major depression with psychotic features according to the electronic medical record.
- Current nicotine use, defined as smoking 5 or more cigarettes/day for at least 16 of the past 30 days prior to study screening.
- Prospective subjects must indicate willingness to attend smoking cessation group therapy.
Exclusion Criteria:
- Imminent risk for suicide or violence.
- Severe psychiatric symptoms or psychosocial instability likely to prevent participation in the study protocol (i.e., attendance at scheduled sessions, ability to read study materials, and/or ability to comprehend interventions).
- Clinically apparent, gross cognitive impairment.
Contacts and LocationsPlease refer to this study by its ClinicalTrials.gov identifier: NCT00508560
| United States, Washington | |
| VA Puget Sound Health Care System | |
| Seattle, Washington, United States, 98109 | |
| Principal Investigator: | Andrew J. Saxon, MD | VA Puget Sound Health Care System |
More Information
No publications provided
| Responsible Party: | Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT00508560 History of Changes |
| Other Study ID Numbers: | SUD-Q |
| Study First Received: | July 27, 2007 |
| Last Updated: | December 12, 2012 |
| Health Authority: | United States: Federal Government |
Keywords provided by Department of Veterans Affairs:
|
Contingency management Smoking cessation Psychotic disorders Veterans |
Additional relevant MeSH terms:
|
Mental Disorders Psychotic Disorders Schizophrenia and Disorders with Psychotic Features |
ClinicalTrials.gov processed this record on February 27, 2015